Meeting Summary
The city council held a special session to discuss and approve the submission of a Letter of Intent for a $23 million opioid settlement grant program. Council members expressed strong support for the initiative and discussed potential partnerships with local nonprofits and university programs. The council also moved to enter executive session to address pending litigation.
Key Decisions & Votes
Opioid Settlement Grant Application
The City Council approved the submission of a Letter of Intent for the $23 million opioid settlement grant program, with plans to develop a full application and explore partnerships with local organizations.
Executive Session for Pending Litigation
The City Council approved adjourning into executive session to discuss pending litigation in the case of Kevin Han versus the City of Norman.
Financial Matters
Opioid Settlement Grant Program
Discussion regarding the opportunity to apply for a $23 million grant from the opioid abatement board to fund programs related to opioid treatment and prevention.
Coming Up
Deadlines
- Letter of Intent for opioid grant due next Wednesday
- Opioid grant applications due in late October (subject to change)
Watch For
- Release of opioid grant application and administrative rules from the Attorney General's office
- Special meeting of the opioid abatement board
- Further discussion on potential partnerships for opioid grant applications
- Formal action on opioid grant Letter of Intent on next Tuesday's agenda
Agenda Summary
Discussion regarding submission of a Grant application for the opioid settlement grant program
Discussion on applying for a $23 million grant from the opioid abatement board, exploring potential partnerships with local organizations, and approving the submission of a Letter of Intent.
Consideration of a journey into executive session as authorized by Oklahoma statutes title 25 section 307 B4 to discuss pending litigation in the case of Kevin Han versus the city of Norman Cleveland Oak Cleveland County District Court case number CJ 2021 2110
Consideration to enter executive session to discuss pending litigation.